Featured News
- Innovate
- Investigate
- Educate
May 15, 2017 – Faculty from the Cardiovascular Research Foundation (CRF) will be presenting research and lectures at EuroPCR 2017 taking place May 16-19 at the Palais des Congrès in Paris, France. They will be sharing the latest research and information on bioresorbable vascular scaffolds, imaging technologies, transcatheter aortic valve replacement, heart failure and other topics.
CRF faculty are world-renowned experts in the field of interventional cardiovascular medicine. Research presentations include the following:
Tuesday, May 16, 2017
Euro17A-OP0530 - Multicenter evaluation of a novel 120µm DeSolve CX BRS: first report of six-month clinical and imaging endpoints
Session: Evolving BRS technology (comprising selected EuroPCR 2017 late-breaking trial submissions)
12:26 PM – 12:39 PM; Level 3, Room 351
Alexandre Abizaid, MD, PhD
Euro17LBT-OP0080 - The FANTOM II study: first report for the 12-month clinical outcomes of the Fantom sirolimus eluting bioresorbable scaffold
Session: Evolving BRS technology (comprising selected EuroPCR 2017 late-breaking trial submissions)
12:52 PM – 1:05 PM; Level 3, Room 351
Alexandre Abizaid, MD, PhD
Wednesday, May 17, 2017
Euro17LBT-OP0053 - Pressure wire compared with microcatheter-based evaluation of coronary fractional flow reserve measurements (PERFORM)
Session: FFR: trials and new techniques (Comprising selected EuroPCR 2017 CV Pipeline submissions)
3:39 PM – 3:57 PM; Level 3, Room 351
Ziad A. Ali, MD, DPhil
Thursday, May 18, 2017
Euro17A-OP1140 - Clinical and imaging predictors of permanent pacemaker implantation after TAVI: an analysis from the PARTNER II SAPIEN 3 study
Session: The impact of conduction disturbances following TAVI (comprising selected EuroPCR 2017 abstract submissions)
9:22 AM – 9:35 AM; Level 3, Room 342B
Tamim Nazif, MD
Euro17A-OP0500 - Compliance with and impact of following a specific OCT stent implantation algorithm: an ILUMIEN III substudy
Session: OCT and IVUS imaging for evaluation of stent-based therapies (comprising selected EuroPCR 2017 late-breaking trial submissions)
10:43 AM – 10:56 AM; Level 2, Room 252A
Mitsuaki Matsumura
Euro17IN-OP0026 - Reinventing the heart valve: bioabsorbable valves enabling cardiovascular restoration
Session: First-in-man studies in tricuspid intervention and myocardial protection (comprising selected EuroPCR 2017 CV Pipeline submissions)
3:37 PM – 3:50 PM, Level 2, Room Maillot
Martin B. Leon, MD
CRF faculty will also be delivering lectures on a variety of topics in the field such as:
Wednesday, May 17, 2017
Critical appraisal of device based interventions in chronic heart failure: opportunities, challenges, and priorities
Session: Device-based management in advanced chronic heart failure: update on clinical development and outcomes
8:35 AM – 8:55 AM; Level 2, Room 242B
Daniel Burkhoff, MD, PhD
Future perspective and potential applications in the interventional arena
Session: Bioresorbable valve therapy: tomorrow's world
9:38 AM – 9:54 AM, Level 3, Room 351
Martin B. Leon, MD
A standardized approach for imaging the tricuspid valve
Session: Tricuspid regurgitation: surgical and transcatheter treatment options
11:07 AM – 11:23 AM; Level 2, Room 241
Rebecca T. Hahn, MD
The ILUMIEN IV trial: OCT guided PCI vs. angiography - An outcome study
Session: Planned and ongoing clinical trials on coronary interventions and imaging
1:52 PM – 2:05 PM; Level 3, Room 343
Ziad A. Ali, MD, DPhil
ECLIPSE - Evaluation of treatment strategies for severe calcific coronary arteries: orbital atherectomy vs. conventional angioplasty technique prior to implantation of DES
Session: Planned and ongoing clinical trials on coronary interventions and imaging
2:18 PM – 2:31 PM; Level 3, Room 343
Gregg W. Stone, MD
Thursday, May 18, 2017
New software to assist the interventional cardiologist in practice
Session: How intravascular imaging can optimize PCI results
11:35 AM – 11:55 AM; Level 2, Room 242B
Ziad A. Ali, MD, DPhil
TAVR UNLOAD trial - TAVR to unload the left ventricle in patients with advanced heart failure: a randomized controlled trial
Session: Planned and ongoing clinical trials on valvular intervention
1:52 PM – 2:05 PM; Level 3, Room 343
Martin B. Leon, MD
Design considerations in functional mitral regurgitation trials
Session: Planned and ongoing clinical trials on valvular intervention
2:05 PM – 2:18 PM; Level 3, Room 343
Ori Ben-Yehuda, MD
The SCOUT II trial: European study to evaluate the Mitralign tricuspid valve annuloplasty system (PTVAS) for symptomatic chronic functional tricuspid regurgitation
Session: Planned and ongoing clinical trials on valvular intervention
Rebecca T. Hahn, MD
2:18 PM – 2:31 PM; Level 3, Room 343
Anatomy of the mitral valve – what interventionists need to know
Session: Transcatheter treatment of mitral regurgitation
Rebecca T. Hahn, MD
2:50 PM – 3:06 PM; Level 3, Theatre Bordeaux
Monitoring fluid status of patients with heart failure using REDS technology: implications for the continuum of care environments
Session: Latest in device-based heart failure management: from concept to FIM
Daniel Burkhoff, MD, PhD
3:23 PM – 3:39 PM; Level 3, Room 351
To learn more about CRF’s research and educational programs at EuroPCR, visit Booth M7 (Level 2).